14.89000 EUR
0.31
2.04%
Last update Dec 16, 8:00 AM CET
Main market
Day range
14.89000
14.89000
Previous close
15.20000
Open
14.89000
Access this stock data via API
Subscribe
Denali Therapeutics Inc.
14.89
0.31
2.04%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 0 330.5M 108.5M 48.7M
Cost of revenue
Gross profit
Operating expense
Research & development 337.9M 423.9M 358.7M 265.4M
Selling general and admin 89.9M 103.4M 90.5M 79.1M
Other operating expenses
Operating income -427.7M -196.7M -340.7M -295.8M
Non operating interest income
Income 55.1M 51.5M 14.8M 4.6M
Expense
Other income expense 12.4M
Pretax income -360.3M -145.2M -326.0M -291.2M
Tax provision 58.0K 30K 21K -575K
Net income -360.3M -145.2M -326.0M -290.6M
Basic EPS -2.6 -1.1 -2.6 -2.4
Diluted EPS -2.6 -1.1 -2.6 -2.4
Basic average shares 140.2M 142.8M 128.9M 124.8M
Diluted average shares 140.2M 142.8M 128.9M 124.8M
EBITDA -432.5M -180.0M -330.4M -287.2M
Net income from continuing op. -360.3M -145.2M -326.0M -290.6M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 9 hours 36 minutes

10:24
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).